WELCOME TO THE

NEW DRUG APPROVALS PAGE!

Below you will find information and links to new cancer therapies or recent FDA changes of approvals of medication offered by NOS Corporate Members!

New Drug Approvals:  

Click link to be directed to product site or PI -

 

ISTODAX (romidepsin)

(Celgene)

 

ZELBORAF (zemurafenib) 

(Genetech/Roche)

 

XALCORI  (crizotinib)

(Pfizer)

 

8/31/11 updated

 
 

Thank you to our Corporate Members!

Nebraska Oncology Society
Midwest Cancer Center
 7500 Mercy Road, Suite 1300
Omaha, NE 68124
Attn: Natalie Mandolfo; Papillion Office

Telephone (402) 690-1397
Fax (402) 593-3145

NOS@COX.NET

 


Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software